A randomized trial of in-hospital initiation of an SGLT2 inhibitor in patients with heart failure missed its endpoint, but a ...

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect ...

Diabetes can also weaken the brain's protective barrier, letting harmful substances in. This leads to inflammation. Reduced ...

Well, for cardiologist Dr Dmitry Yaranov (who goes by Heart Transplant Doc on social media), there are five rules he said he ...

As the prevalence of both chronic kidney disease (CKD) and heart failure (HF) increases, therapies targeting shared pathways ...

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect ...

Phase 1 data in healthy volunteers exceed expectations and support best-in-class potential, enabling Phase 2 advancement for ...

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect brain health and vice versa ...

With studies showing potential for SGLT2 inhibitors in heart failure, a study of HCP online conversations reveals cardiologists are still cautious. AstraZeneca had already been quick to consider the ...

The drug lowered inflammation, oxidative stress, and endothelial injury markers in women with INOCA and coronary ...

Maze's MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and ...